TY - JOUR T1 - Down-regulated MicroRNAs in Gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement Therapy JF - Anticancer Research JO - Anticancer Res SP - 4185 LP - 4202 DO - 10.21873/anticanres.15223 VL - 41 IS - 9 AU - ULRICH H. WEIDLE AU - FABIAN BIRZELE AU - SIMON AUSLAENDER AU - ULRICH BRINKMANN Y1 - 2021/09/01 UR - http://ar.iiarjournals.org/content/41/9/4185.abstract N2 - Gastric cancer is one of the leading types of cancer with an annual death toll of 700,000 worldwide. Despite the fact that several agents are approved for its treatment, high percentage of recurrence and intractability of metastatic disease remain a major problem. The identification of new targets and modalities for treatment are therefore of high priority. We have searched the literature for microRNAs down-regulated in gastric cancer with efficacy in gastric cancer-related murine xenograft models after reconstitution therapy. Among the identified miRs were 25 miRs targeting transcription factors, seven of them regulating cell-cycle and apotosis-related targets, and five of them regulating GTPase-related targets such as GAPs and GEFs. According to criteria such as prognostic impact, functional data, and tractability, miR-133 b/a (MCL1) and miR-518 (MDM2) are suggested as potentially valuable targets for further evaluation and possible treatment of gastric cancer. ER -